Wearable-Echo-FM detected structural heart diseases from 1-lead ECGs using only 0.5% of training data, markedly outperforming a baseline model (AUROC 0.819-0.863 vs 0.496-0.582).
Does Wearable-Echo-FM improve the detection of structural heart diseases from 1 lead ECGs compared to a randomly initialized CNN?
Contrastive pre-training of 1 lead ECGs with echocardiographic text reports significantly reduces the amount of labeled data required to develop accurate AI screening models for structural heart disease.
Tasa de eventos absoluta: 0% vs 0%
Abstract Background Artificial intelligence (AI) models can now detect patterns of structural heart diseases (SHDs) from electrocardiograms (ECGs), though scaling them requires the broader use of 1 lead ECGs that are now ubiquitous in wearable and portable devices. However, model development for these devices is limited by a lack of diagnostic labels for SHDs for wearable ECGs. Methods Here, we present Wearable-Echo-FM, a foundation model that encodes 1 lead ECGs with information from echocardiographic text reports. Using 194,551 1 lead ECG echo pairs from 77,378 adults (2015-2018), we contrastively pre-trained convolutional neural network (CNN) and RoBERTa encoders. The ECG encoder was fine-tuned on a distinct progressively larger ECG set (250 to 250,260 ECGs) to detect different cardiac disorders (i) left-ventricular systolic dysfunction (LVSD), (ii) diastolic dysfunction, and (iii) a composite SHD. This was compared with a randomly initialized CNN, with both approaches evaluated in an independent held out test set. Results With the full training set, Wearable-Echo-FM matched the baseline CNN (AUROC 0.894 vs 0.884 for LVSD; 0.849 vs 0.843 diastolic dysfunction; 0.887 vs 0.869 composite). With only 0.5% (∼1000 ECGs) of data, it markedly outperformed baseline (0.855 vs 0.548; 0.819 vs 0.582; 0.863 vs 0.496, respectively). Conclusions Contrastive pre-training of 1 lead ECGs on echocardiographic text reduces label requirements for label efficient development of SHD screening models on 1 lead ECGs, providing a foundation for future validation on wearable and portable devices.
Knight et al. (Tue,) reported a other. Wearable-Echo-FM detected structural heart diseases from 1-lead ECGs using only 0.5% of training data, markedly outperforming a baseline model (AUROC 0.819-0.863 vs 0.496-0.582).